Suppr超能文献

病例报告:1例具有微卫星高度不稳定表型的同步多发早期胃癌病例。

Case Report: A case of synchronous multiple early gastric cancer with a microsatellite instability-high phenotype.

作者信息

Wang Xinshuo, Zhang Yifan, Fan Guangyan, Wu Honglei, Qi Xing, Cui Xiujie, Zhou Chengjun

机构信息

Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

Department of Gastroenterology, The Second Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

出版信息

Front Oncol. 2025 Apr 3;15:1527495. doi: 10.3389/fonc.2025.1527495. eCollection 2025.

Abstract

Synchronous multiple early gastric cancer (SMEGC) is a relatively uncommon variant of early gastric cancer (EGC). In this report, we present a case of SMEGC accompanied by a microsatellite instability-high (MSI-H) phenotype. The patient was a 69-year-old man who presented to our hospital with abdominal pain. The endoscopic examination revealed two lesions. Both lesions were pathologically confirmed as EGC, then the patient subsequently underwent endoscopic submucosal dissection (ESD). Nine months post-procedure, the patient returned with recurrent abdominal pain, leading to the diagnosis of a new EGC. Immunohistochemical analysis demonstrated that all lesions exhibited an MSI-H phenotype and BRAF mutant expression, suggesting that these lesions are not associated with Lynch syndrome-related EGC. The case was ultimately diagnosed as SMEGC with an MSI-H phenotype. The current evidence and clinical experience suggest that patients with advanced MSI-H are likely to benefit from immunotherapy and should be considered for early systemic treatment with immunotherapy as a central component. At present, research studies on the molecular characteristics of SMEGC are limited, underscoring the importance of conducting comprehensive molecular diagnostics of each EGC patient, which could help clinicians thoroughly understand the lesion's characteristics.

摘要

同步性多原发性早期胃癌(SMEGC)是早期胃癌(EGC)中一种相对罕见的类型。在本报告中,我们呈现了一例伴有微卫星高度不稳定(MSI-H)表型的SMEGC病例。该患者为一名69岁男性,因腹痛前来我院就诊。内镜检查发现两个病灶。两个病灶经病理证实均为EGC,随后患者接受了内镜下黏膜下剥离术(ESD)。术后9个月,患者因复发性腹痛复诊,诊断为新发EGC。免疫组化分析显示,所有病灶均表现为MSI-H表型和BRAF突变表达,提示这些病灶与林奇综合征相关的EGC无关。该病例最终被诊断为具有MSI-H表型的SMEGC。目前的证据和临床经验表明,晚期MSI-H患者可能从免疫治疗中获益,应考虑将免疫治疗作为核心组成部分进行早期全身治疗。目前,关于SMEGC分子特征的研究有限,这凸显了对每位EGC患者进行全面分子诊断的重要性,这有助于临床医生全面了解病灶特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/12003148/0cd277f8e30e/fonc-15-1527495-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验